KIF24 and breast cancer: By normalizing the expression profiles of Kif24 and Nek2 with HMECs, we found that Kif24 protein levels were comparable or modestly elevated across the panel of cell lines, whereas Nek2 was strongly upregulated (∼5–30-fold) in all breast cancer cell lines that we examined (Supplementary Fig. 12A–C).